1 | MS | 2.06% | |
2 | Global | 1.55% | |
3 | Rare | 1.55% | |
4 | Weight | 1.55% | |
5 | Disease | 1.55% | |
6 | Big | 1.03% | |
7 | Study | 1.03% | |
8 | Heart | 1.03% | |
9 | Future | 1.03% | |
10 | Australia | 1.03% | |
11 | Coastal | 1.03% | |
12 | Health | 1.03% | |
13 | Day | 1.03% | |
14 | Waters | 1.03% | |
15 | Kidney | 1.03% | |
16 | Flooding | 1.03% | |
17 | Research | 1.03% | |
18 | Centre | 1.03% | |
19 | Fecal | 1.03% | |
20 | Sunny | 1.03% | |
21 | Treatments | 1.03% | |
22 | News | 1.03% | |
23 | Chemical | 1.03% | |
24 | Diagnosis | 1.03% | |
25 | Vary | 0.52% | |
26 | Vilvang | 0.52% | |
27 | Increases | 0.52% | |
28 | Gain | 0.52% | |
29 | Immunization | 0.52% | |
30 | Enduring | 0.52% | |
31 | TCT | 0.52% | |
32 | Bernis | 0.52% | |
33 | Boost | 0.52% | |
34 | ECU | 0.52% | |
35 | Tour | 0.52% | |
36 | Could | 0.52% | |
37 | Antibodies | 0.52% | |
38 | High | 0.52% | |
39 | American | 0.52% | |
40 | PET | 0.52% | |
41 | Medical | 0.52% | |
42 | Commercial | 0.52% | |
43 | Internalized | 0.52% | |
44 | National | 0.52% | |
45 | Guidelines | 0.52% | |
46 | Womens | 0.52% | |
47 | Therapy | 0.52% | |
48 | Uncover | 0.52% | |
49 | Family | 0.52% | |
50 | Tessa | 0.52% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
Tour de Cure backs further development of Noxopharm's preclinical brain cancer candidate
The National Tribune
2024-04-23 14:38:15